Clinical trials: Relapsing-Remitting Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis
The aim of the study is to determine whether a therapeutic strategy combining mitoxantrone and interferon beta1b can delay disease progression of at least one point on EDSS scale in patients with clinically very active…
- Trial name
- NCT00219908
- Testing
- Mitoxantrone
- Where
- 23 sites in France, Italy
- Volunteers
- 124 people
- Sponsor
- Rennes University Hospital
Relapsing Remitting Multiple Sclerosis
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
The purpose of this study is to determine if using Avonex in combination with Zocor is a safe and effective therapy for subjects with relapsing remitting multiple sclerosis.
- Trial name
- NCT00242268
- Testing
- Simvastatin
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Alabama Neurology Associates, PC
Multiple Sclerosis
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
This is a clinical trial in relapsing-remitting Multiple Sclerosis to determine if Topamax added to Avonex has a neuroprotective effect as measured by the brain parenchymal fraction ( a measure of brain shrinkage) and by clinical…
- Trial name
- NCT00217295
- Testing
- Avonex and Topamax
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Multiple Sclerosis Institute